Medalginan

Diethylamine Salicylate, the active ingredient in Medalginan, is a salicylate (NSAID) presented as a topical formulation for skin application. It is used to provide local analgesic and anti‑inflammatory effects for minor musculoskeletal discomfort in adults. GNH USA supplies Medalginan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Medalginan, a topical salicylate NSAID, is applied to conditions involving superficial musculoskeletal inflammation. - Minor muscle aches: reduces pain and stiffness in over‑used muscles. - Joint sprains: alleviates swelling and discomfort in ligaments. - Tendonitis: helps diminish localized inflammation of tendons. - Bruising: provides soothing relief from mild contusion pain.

Topical application of Medalginan may be associated with local and systemic reactions.

Common Side Effects: - Skin irritation: mild redness or itching at the application site. - Burning sensation: transient warmth or tingling after use. - Dryness: localized skin dryness or flaking.

Serious or Rare Side Effects: - Allergic dermatitis: severe rash, swelling, or hives. - Contact urticaria: immediate swelling and itching. - Systemic NSAID effects: rare gastrointestinal upset if absorbed in large amounts. - Photosensitivity: increased skin sensitivity to sunlight.

When using Medalginan, consider the following safety measures. - Avoid broken skin: do not apply to open wounds or irritated skin. - Limit area: restrict use to the recommended surface area to prevent excess absorption. - Monitor for allergy: discontinue if signs of allergic reaction appear. - Pregnancy and lactation: consult a healthcare professional before use. - Drug interactions: inform the prescriber of concurrent NSAID or anticoagulant use. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Medalginan may interact with other agents that affect bleeding or prostaglandin pathways.

Major Interactions (Avoid): - Systemic NSAIDs: concurrent use can increase risk of gastrointestinal bleeding. - Anticoagulants (e.g., warfarin): may enhance anticoagulant effect and bleeding risk.

Moderate Interactions (Monitor Closely): - Corticosteroid creams: combined use may increase skin thinning. - Diuretics: monitor for electrolyte disturbances if systemic absorption occurs. - Alcohol: excessive intake may heighten gastrointestinal irritation.